- Home
- YRD vs PROK Comparison
YRD vs PROK Comparison
Compare YRD & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | YRD | PROK |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 321.4M | 359.1M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | YRD | PROK |
|---|---|---|
| Price | $1.43 | $1.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.40 |
| AVG Volume (30 Days) | 124.3K | ★ 817.9K |
| Earning Date | 06-11-2026 | 05-08-2026 |
| Dividend Yield | ★ 23.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.86 | ★ N/A |
| Revenue Growth | N/A | ★ 1075.00 |
| 52 Week Low | $1.32 | $0.54 |
| 52 Week High | $7.68 | $7.13 |
Technical Indicators
Market Signals| Indicator | YRD | PROK |
|---|---|---|
| Relative Strength Index (RSI) | 24.37 | 52.33 |
| Support Level | N/A | $1.73 |
| Resistance Level | $2.15 | $2.58 |
| Average True Range (ATR) | 0.12 | 0.12 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 9.58 | 77.50 |
Price Performance
Historical ComparisonAbout YRD Yiren Digital Ltd.
Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.